Status:
TERMINATED
Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department
Lead Sponsor:
Children's Mercy Hospital Kansas City
Collaborating Sponsors:
Blue Cross Blue Shield
Conditions:
Abscess
Eligibility:
All Genders
3-17 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if there is a difference between an antibiotic, trimethoprim-sulfamethoxazole versus placebo in healing outcomes of soft tissue abscesses following incision a...
Eligibility Criteria
Inclusion
- Age 3 months to 17 years
- Single, localized soft tissue abscesses requiring incision and drainage with purulent material obtained
- Diameter of the abscess less than 5cm as measured by the treating physician
Exclusion
- Signs of systemic illness or ill-appearing, as determined by the treating physician
- Admission to the hospital following treatment in the Emergency Department
- Known sulfa allergy
- Immunocompromised patients
- Soft tissue abscesses involving the perineum (labia, scrotum, penis, perirectal)
- Previous antibiotic use (for any reason) in the past seven days
- Non-English speaking patients and families
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00867789
Start Date
March 1 2009
End Date
October 1 2012
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Mercy Hospitals and Clinics
Kansas City, Missouri, United States, 64108